ALS AMYOTROPHIC LATERAL SCLEROSIS

ALS AMYOTROPHIC LATERAL SCLEROSIS

ALS also known as Lou Gehrig’s disease is a debilitating neurologic disease that results from the destruction of upper and lower motor neurons in the brain and spinal cord. ALS is associated with rapidly progressive weakness, muscle wasting, spasticity, and difficulty breathing, swallowing and speaking. There is no known cause for ALS and genetics are implicated in only 5% of cases. There is no known cure for the physical defects associated with ALS. Many investigators are looking at using the regenerative properties of cell therapy to mitigate the impact of ALS on the nervous system.  We have developed a specific SVF deployment protocol that attempts to utilize the immuno-regulatory, regenerative, and anti-inflammatory properties of SVF (rich in mesenchymal stem cells and growth factors). Special measures are taken to optimize transport of the SVF across the blood-brain barrier to improve central nervous system uptake. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire procedure takes approximately three hours.

Brooklyn

2519 Avenue O
Brooklyn, NY 11210

Manhattan

200 Chambers Street
New York, NY 10007